Quantcast

Latest Osteoporosis Stories

2014-10-08 12:25:07

Registry is a New Powerful Tool for Health Care Professionals to Improve Quality of Care and Meet Physician Quality Reporting System/Meaningful Use Reporting Requirements WASHINGTON, Oct. 8, 2014 /PRNewswire-USNewswire/ -- The National Osteoporosis Foundation (NOF) and National Bone Health Alliance (NBHA) Osteoporosis Quality Improvement Registry (QIR), developed in collaboration with CECity, Inc., as a Qualified Clinical Data Registry (QCDR) for the CMS Physician Quality Reporting System...

2014-10-08 08:27:17

LOS ANGELES, Oct. 8, 2014 /PRNewswire/ -- Extensive research has shown that vitamin D deficiencies play a major role in the development of dozens of diseases, including breast, prostate and colon cancer, as well as diabetes, heart disease, arthritis, osteoporosis, psoriasis and mental illness. While many people are beginning to realize the health benefits that vitamin D has to offer in the prevention of disease, they may not be getting the full benefits from vitamin D without also...

2014-10-06 08:28:20

FLOWOOD, Miss., Oct. 6, 2014 /PRNewswire/ -- Zavation, LLC., today announced the launch of the ZVPlasty(TM) Vertebral Augmentation System. The Zavation ZVPlasty(TM) is designed for use in vertebroplasty or kyphoplasty procedures for the treatment of vertebral compression fractures in the lumbar or thoracic regions brought on by primary or secondary osteoporosis, cancer or trauma. The Zavation ZVplasty(TM) system includes a streamlined set of manual instruments which provide...

2014-10-02 08:30:12

Falls are one of the leading causes of injuries in senior citizens. A trusted NYC nursing home, Gold Crest Care Center, offers fall prevention tips for seniors. BRONX, N.Y., Oct. 2, 2014 /PRNewswire/ -- Gold Crest Care Center, a leading Bronx rehabilitation facility for senior citizens, urges seniors and their families to recognize the dangers of fall related injuries in senior citizens. Fall related injuries are currently ranked as the leading cause of death in those over the age of...

2014-10-01 04:21:52

Encouraging men and women worldwide to discover the surprising bone health benefits of Sunsweet Amaz!n Prunes YUBA CITY, Calif., Oct. 1, 2014 /PRNewswire/ -- According to the World Osteoporosis Organization, approximately one in three women and one in five men over the age of 50 will suffer an osteoporotic fracture in their remaining lifetime. For women, the risk of hip fracture is higher than the risk of breast, ovarian and uterine cancer combined(i). Luckily, according to the...

2014-09-30 23:10:26

The European trauma fixation devices report defines and segments the concerned market in Europe with analysis and forecast of revenue.http://www.micromarketmonitor.com/market/europe-trauma-fixation-devices-8600467081.html (PRWEB) September 30, 2014 The trauma fixation devices market in Europe is estimated to grow to $2,542.7 million by 2018, at a CAGR of 6.5% from 2013 to 2018. Browse through the TOC of the European trauma fixation devices market, to get an idea of the in-depth analysis...

2014-09-29 23:04:56

The North American orthobiologics report defines and segments the concerned market in North America with analysis and forecast of revenue. http://www.micromarketmonitor.com/market/north-america-orthobiologics-9077664565.html (PRWEB) September 29, 2014 The orthobiologics market in North America is estimated to grow to around $4796.3 million by 2018, at a developing CAGR of 7.2% from 2013 to 2018. Browse through the TOC of the North American orthobiologics market, to get an idea of the...

2014-09-24 12:30:16

Minivelle now approved for prevention of postmenopausal osteoporosis at all doses MIAMI and NEW YORK, Sept. 24, 2014 /PRNewswire/ -- Noven Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved a new indication with a new dose of Minivelle (estradiol transdermal system) for the prevention of postmenopausal osteoporosis. The FDA initially approved Minivelle in October 2012 to treat moderate to severe vasomotor symptoms (VMS) due to...

2014-09-15 16:29:02

Data Presented at the American Society of Bone and Mineral Research 2014 Annual Meeting THOUSAND OAKS, Calif., Sept. 15, 2014 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced results from a new exploratory analysis of the open-label extension study of the pivotal Phase 3 fracture trial, which found that treatment with Prolia(®) (denosumab) for eight years enabled a substantial proportion of women with osteoporosis to achieve non-osteoporotic T-scores (>-2.5) at the lumbar spine and...

2014-09-15 16:28:40

Romosozumab Currently in Phase 3 Clinical Development, Pivotal Data Expected in 2016 THOUSAND OAKS, Calif. and BRUSSELS, Sept. 15, 2014 /PRNewswire/ -- Amgen (NASDAQ:AMGN) and UCB (Euronext Brussels:UCB) today announced results from several exploratory analyses of the Phase 2 study evaluating romosozumab in postmenopausal women with low bone mineral density (BMD). Romosozumab is an investigational bone-forming agent that is designed to work by inhibiting the protein sclerostin, thereby...


Latest Osteoporosis Reference Libraries

Osteoporosis International
2012-05-17 15:25:40

Osteoporosis International is a peer-reviewed medical journal published monthly by Springer Science+Business Media. It was established in 1990. It is the official journal of the International Osteoporosis Foundation and the National Osteoporosis Foundation. The journal includes original research on all areas of osteoporosis and related fields. It also publishes reviews, educational articles, and case reports. Editors-in-chief are R. Lindsay and J.A. Kanis. According to the Journal...

More Articles (1 articles) »
Word of the Day
bellycheer
  • Good cheer; viands.
  • To revel; to feast.
The word 'bellycheer' may come from 'belle cheer', "good cheer".
Related